Patents by Inventor Sean McGill

Sean McGill has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11851462
    Abstract: Testing peptides in in vitro models of neurodegenerative disorders such as Parkinson's disease, Alzheimer's disease, Frontotemporal dementia, Amyotrophic lateral sclerosis, to evaluate systems and methods of treatment therefore.
    Type: Grant
    Filed: May 22, 2020
    Date of Patent: December 26, 2023
    Assignee: University of South Carolina
    Inventors: Amar N. Kar, Pabitra Sahoo, Jeffery Twiss, Sean McGill
  • Publication number: 20230190887
    Abstract: Testing peptides in in vitro models of neurodegenerative disorders such as Parkinson's disease, Alzheimer's disease, Frontotemporal dementia, Amyotrophic lateral sclerosis, to evaluate systems and methods of treatment therefore.
    Type: Application
    Filed: November 18, 2022
    Publication date: June 22, 2023
    Applicants: University of South Carolina, Ramot at Tel-Aviv University Ltd., Tel HaShomer Medical Research Infrastructure and Services Ltd.
    Inventors: Amar N. Kar, Pabitra Sahoo, Jeffery Twiss, Sean McGill, Eran Perlson, Topaz Altman, Ariel Razvan Ionescu, Tal Gradus-Pery, Amir Dori
  • Publication number: 20210024591
    Abstract: Testing peptides in in vitro models of neurodegenerative disorders such as Parkinson's disease, Alzheimer's disease, Frontotemporal dementia, Amyotrophic lateral sclerosis, to evaluate systems and methods of treatment therefore.
    Type: Application
    Filed: May 22, 2020
    Publication date: January 28, 2021
    Applicant: University of South Carolina
    Inventors: Amar N. Kar, Pabitra Sahoo, Jeffery Twiss, Sean McGill